Targeting planktonic uropathogens and Escherichia coli biofilm with photodynamic therapy mediated by methylene blue and potassium iodide (2026)

Peer-Reviewed Study · Silva D, Mendonça I, Vieira C, et al. · August 27, 2026

Silva D et al., 2026-08-27: Ex-vivo urine study showing methylene blue plus potassium iodide photodynamic therapy reduces uropathogens and E. coli biofilm on catheter surfaces. In-vitro/ex-vivo only.

The combined action of MB and KI successfully controlled E. coli biofilms, achieving reductions of 3.9 (> 99.987%) and 6.0 log10 CFU mL-1 after one and two aPDT treatment cycles, respectively.

Silva D et al., 2026-08-27: Ex-vivo urine study showing methylene blue plus potassium iodide photodynamic therapy reduces uropathogens and E. coli biofilm on catheter surfaces. In-vitro/ex-vivo only. Study type: ex vivo assays in urine with clinical uropathogens and catheter biofilm. N/A. Country: Portugal (University of Aveiro). MB alone and MB + KI; light parameters not stated in abstract. Funding: not stated in record. Conflicts: none declared. Comparator: MB alone, untreated. MB alone was least effective against K. pneumoniae and P. aeruginosa. Also filed as MTL-084 (claims C5, C7). Study type: lab.